Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law

Intellectual Property Law

: Orange Book Blog: At the Intersection of Patent Law and FDA Law

Hatch-Waxman Tracker Update

By Aaron Barkoff

For the current version of the Hatch-Waxman Tracker, please click here.

New cases added:

• Aricept:  Eisai v. Teva
• Asacol:  Medeva v. Roxane
• Astelin:  Medpointe v. Cobalt (D.N.J.); MedPointe v. Cobalt (N.D. Ill.)
• Avinza:  King v. Actavis
• Boniva:  Hoffman-LaRoche v. Apotex; v. Cobalt; v. Dr. Reddy's; v. Gate; v. Genpharm; v. Mutual; v. Orchid; v. Teva
• Clarinex-D:  Schering v. Reddy's
• Combivir:  Glaxo v. Teva
• Comtan:  Orion v. Wockhardt
• Diovan:  Novartis v. Ranbaxy
• Femcon Fe:  Warner Chilcott v. Barr; v. Watson
• Focalin XR:  Celgene/Novartis v. Actavis; v. Intellipharmaceutics; v. Teva; Elan v. Actavis; v. Intellipharmaceutics
• Luxiq:  Connetics v. Pentech
• Mucinex:  Adams Respiratory v. Perrigo
• Ritalin LA:  Celgene v. Barr; v. KV
• Stalevo:  Orion v. Sun
• Strattera:  Eli Lilly v. Actavis; v. Aurobindo; v. Sun; v. Synthon; Sandoz v. Lilly
• Sular:  Sciele v. Mylan
• Taxotere:  Sanofi-Aventis v. Hospira
• Uroxatral:  Sanofi-Aventis v. Actavis et al.; v. Aurobindo; v. Barr; v. Mylan; v. Torrent
• Yaz:  Bayer v. Watson
• Zanaflex:  Acorda v. Apotex
• Zegerid:  Santarus v. Par

Pending cases updated:

• Acular:  Roche v. Apotex
• Allegra:  Aventis v. Mylan
• Allegra-D 24 Hour:  Aventis v. Dr. Reddy's
• Altace:  Aventis/King v. Lupin
• Avelox:  Bayer v. Dr. Reddy's
• Clarinex:  Schering v. Dr. Reddy's;  v. Lupin; v. Mylan; v. Orchid; v. Perrigo; v. Ranbaxy; v. Sun; Sepracor v. Dr. Reddy's
• Depakote:  Abbott v. Torpharm/Apotex
• Eloxatin:  Sanofi-Aventis v. Mayne; v. Teva
• Famvir:  Novartis v. Teva
• Focalin:  Elan v. Teva
• Lexapro:  Forest v. Ivax/Cipla
• Lotrel:  Novartis v. Mylan
• Neurontin:  In re Gabapentin Litigation
• OxyContin:  Purdue Pharma v. Apotex
• Patanol: Alcon v. Barr
• Protonix:  Altana/Wyeth v. Teva
• Thalomid:  Celgene v. Barr
• Ultram ER:  Purdue Pharma v. Par
• Univasc:  Schwarz Pharma v. Paddock Labs

Cases removed:

• Flomax:  Astellas/Boehringer Ingelheim v. Ranbaxy (settled)
• Norvasc:  Pfizer v. Apotex (cert denied)
• Paxil CR:  GSK v. Mylan (settled)

Special thanks for help with this update go to Kirsten Thomson, an associate at MBHB.

Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on November 14, 2007 (boomark / email).